The burden of chronic drug-refractory focal onset epilepsy: Can it be prevented?

Document Type

Journal Article

Publication Date

9-23-2023

Journal

Epilepsy & behavior : E&B

Volume

148

DOI

10.1016/j.yebeh.2023.109435

Keywords

Add-on; Burden of disease; Drug-resistant epilepsy (DRE); Focal onset seizures; Quality of life (QoL); Third generation antiseizure medications (ASMs)

Abstract

Despite the many therapeutic options for epilepsy available today, a third of patients still have poorly controlled epilepsy. Over the years, their transition through lines of treatment exposes them to increased risk of disease progression, mortality, morbidity, mental distress, and not least significantly impaired quality of life (QoL). The present review explores the multiple factors contributing to the impairment of health-related QoL in PWE-including both seizure-related and non seizure-related. The analysis aims to identify potential areas of intervention and strategies for a more holistic approach to epilepsy care and inform policy-makers and healthcare providers in their approach to this condition.

Department

Neurology

Share

COinS